SEROQUEL (QUETIAPINE)
SEROQUEL (QUETIAPINE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: SEROQUEL; Generic name: QUETIAPINE; Manufacturer: AstraZeneca Pharmaceuticals LP.
| Brand name | SEROQUEL |
|---|---|
| Generic name | QUETIAPINE |
| Manufacturer | AstraZeneca Pharmaceuticals LP |
| Used for | 1 INDICATIONS AND USAGE SEROQUEL is an atypical antipsychotic indicated for the treatment of: • Schizophrenia ( 1.1 ) • Bipolar I disorder manic episodes (1.2) • Bipolar disorder, depressive episodes (1.2) 1.1 Schizophrenia SEROQUEL is indicated for the treatment of schizophrenia. The efficacy of SEROQUEL in schizophrenia was established in three 6-week trials in adults and one 6-week trial in adolescents (13-17 years). The effectiveness of SEROQUEL for the maintenance treatment of schizophrenia has not been systematically evaluated in controlled clinical trials [see Clinical Studies (14.1) ]. 1.2 Bipolar Disorder SEROQUEL is indicated for the acute treatment of manic episodes associated wit |
| Dosage | 2 DOSAGE AND ADMINISTRATION • SEROQUEL can be taken with or without food (2.1) Indication Initial Dose Recommended Dose Maximum Dose Schizophrenia - Adults (2.2) 25 mg twice daily 150-750 mg/day 750 mg/day Schizophrenia - Adolescents (13-17 years) (2.2) 25 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania - Adults Monotherapy or as an adjunct to lithium or divalproex (2.2) 50 mg twice daily 400-800 mg/day 800 mg/day Bipolar Mania - Children and Adolescents (10-17 years), Monotherapy (2.2) 2 |
| Warnings | WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS; and SUICIDAL THOUGHTS AND BEHAVIORS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death [see Warnings and Precautions (5.1) ] . SEROQUEL is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1) ] . Suicidal Thoughts and Behav |
| Active ingredient(s) | QUETIAPINE FUMARATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0584dda8-bc3c-48fe-1a90-79608f78e8a0 |